Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Obstet Gynecol
    December 2024

  1. ACOG Committee Statement No. 13: Self-Managed Abortion.
    Obstet Gynecol. 2024;144:e152-e159.
    >> Share

    November 2024
  2. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2024 Nov 1. doi: 10.1097/AOG.0000000000005796.
    >> Share

    September 2024
  3. CASTANO PM
    Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context.
    Obstet Gynecol. 2024;144:291-293.
    >> Share

    August 2024
  4. WERNICK HJ, Abdel-Rasoul M, Berlan ED, Bonny AE, et al
    Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant.
    Obstet Gynecol. 2024 Aug 30. doi: 10.1097/AOG.0000000000005712.
    >> Share


  5. Rates of Female Sterilization, Vasectomy, and LARC Placement Before and After the Dobbs Decision: A Retrospective Cohort Study [ID 2683404].
    Obstet Gynecol. 2024;144:e46.
    >> Share

    July 2024
  6. BULLARD KA, Ramanadhan S, Caughey AB, Rodriguez MI, et al
    Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Jul 25. doi: 10.1097/AOG.0000000000005679.
    >> Share

    May 2024
  7. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005621.
    >> Share

  8. MEYER R, Toussia-Cohen S, Shats M, Segal O, et al
    24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005535.
    >> Share

    April 2024
  9. MURPHY E, Pelletier A, Fay K, Bartz D, et al
    National Postpartum Permanent Contraception Practices and Perceived Barriers.
    Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584.
    >> Share

    February 2024

  10. Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    >> Share

    January 2024
  11. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    >> Share

  12. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    >> Share


  13. ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    >> Share

    December 2023
  14. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    >> Share

  15. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    >> Share

    November 2023
  16. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    >> Share

  17. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    >> Share

  18. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    >> Share

    October 2023
  19. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    >> Share

  20. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    >> Share


  21. Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    >> Share

    September 2023
  22. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    >> Share

    August 2023
  23. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    >> Share

  24. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    >> Share

    July 2023
  25. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    >> Share


  26. Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    >> Share


  27. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    >> Share

    May 2023
  28. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    >> Share

  29. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    >> Share

  30. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    >> Share

  31. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    >> Share

    April 2023
  32. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    >> Share

  33. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    >> Share

  34. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    >> Share

  35. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    >> Share

  36. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    >> Share


  37. Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    >> Share

    March 2023
  38. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    >> Share

    February 2023
  39. MADISON AM, Powers D, Maslowsky J, Goyal V, et al
    Association Between Publicly Funded Contraceptive Services and the Abortion Rate in Texas, 2010-2015.
    Obstet Gynecol. 2023;141:361-370.
    >> Share

    January 2023
  40. PEARLMAN SHAPIRO M, Dethier D, Kahili-Heede M, Kaneshiro B, et al
    No-Test Medication Abortion: A Systematic Review.
    Obstet Gynecol. 2023;141:23-34.
    >> Share

    December 2022
  41. WU J, Trahair E, Happ M, Swartz J, et al
    TikTok, #IUD, and User Experience With Intrauterine Devices Reported on Social Media.
    Obstet Gynecol. 2022 Dec 6. doi: 10.1097/AOG.0000000000005027.
    >> Share

    November 2022
  42. UWANAKA O, Qureshey E, Wagner SM, Gupta M, et al
    Temporal Changes in Counseling for and Use of Emergency Contraception.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00611.
    >> Share

  43. ANTHONY MS, Zhou X, Schoendorf J, Reed SD, et al
    Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Obstet Gynecol. 2022 Nov 3. pii: 00006250-990000000-00606.
    >> Share

    October 2022
  44. BAKER CC, Creinin MD
    Long-Acting Reversible Contraception.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00599.
    >> Share

  45. COLEMAN-MINAHAN K, Boniface ER, Fuentes-Rivera E, Saavedra-Avendano B, et al
    Patterns in Contraceptive Use Among Women of Mexican Origin in the United States and in Mexico.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00582.
    >> Share

  46. ROMANSKI PA, Gelvin B, Bortoletto P, Rosenwaks Z, et al
    Live-Birth Outcomes Among Women With Infertility and Anti-Mullerian Hormone Levels of 0.3 ng/mL or Lower.
    Obstet Gynecol. 2022 Oct 6. pii: 00006250-990000000-00590.
    >> Share

  47. PANKO TL
    Reproductive Justice for the Deaf Community.
    Obstet Gynecol. 2022;140:560-564.
    >> Share

    September 2022

  48. General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.
    Obstet Gynecol. 2022;140:528-541.
    >> Share

  49. CIRUCCI C, Harrison D, Francis C
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;140:519.
    >> Share

  50. COCKRUM RH, Soo J, Ham SA, Cohen KS, et al
    Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
    Obstet Gynecol. 2022;140:477-487.
    >> Share

    August 2022
  51. ELGEMARK K, Graner S, McTaggart J, Ramirez Lofstrom J, et al
    The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
    Obstet Gynecol. 2022;140:227-233.
    >> Share

    July 2022
  52. MARTINEZ OP, Wilder L, Seal P
    Ultrasound-Guided Compared With Non-Ultrasound-Guided Placement of Immediate Postpartum Intrauterine Contraceptive Devices.
    Obstet Gynecol. 2022;140:91-93.
    >> Share

  53. EDELMAN AB, Hennebold JD, Bond K, Lim JY, et al
    Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;140:48-54.
    >> Share

    June 2022
  54. ROE AH, Abernathy A, Flynn AN, McAllister A, et al
    Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
    Obstet Gynecol. 2022;139:1149-1151.
    >> Share

  55. BIGGS MA, Ehrenreich K, Morris N, Blanchard K, et al
    Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product.
    Obstet Gynecol. 2022;139:1111-1122.
    >> Share

    May 2022
  56. PAKEY J, Nassim JS, Reynolds RV
    Hormonal Intrauterine Devices and Acne.
    Obstet Gynecol. 2022;139:919-921.
    >> Share

  57. PETERSON SF, Lerma K, Shaw KA, Blumenthal PD, et al
    Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions.
    Obstet Gynecol. 2022;139:907-909.
    >> Share

  58. HARMON QE, Patchel SA, Zhao S, Umbach DM, et al
    Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
    Obstet Gynecol. 2022;139:797-807.
    >> Share

  59. RODRIGUEZ MI, Manibusan B, Kaufman M, McConnell KJ, et al
    Association of Pharmacist Prescription of Contraception With Breaks in Coverage.
    Obstet Gynecol. 2022;139:781-787.
    >> Share

  60. GOLDBERG AB, Fulcher IR, Fortin J, Hofer RK, et al
    Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
    Obstet Gynecol. 2022;139:771-780.
    >> Share

  61. KOPP-KALLNER H, Linder M, Cesta CE, Segovia Chacon S, et al
    Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
    Obstet Gynecol. 2022;139:764-770.
    >> Share

    April 2022
  62. LAZORWITZ A, Pena M, Sheeder J, Teal S, et al
    Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2022;139:579-587.
    >> Share

  63. QURESHEY EJ, Chauhan SP, Wagner SM, Batiste O, et al
    Educational Multimedia Tool Compared With Routine Care for the Uptake of Postpartum Long-Acting Reversible Contraception in Individuals With High-Risk Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2022;139:571-578.
    >> Share

    March 2022
  64. BRANT AR, Batur P, Arrigain S, Lopez R, et al
    Out-of-Pocket Expenditures for Contraceptives During State Medicaid Expansion, 2013-2016.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00411.
    >> Share

  65. BURGER T, Li J, Zhao Q, Schreiber CA, et al
    Association of Obesity With Longer Time to Pregnancy.
    Obstet Gynecol. 2022 Mar 10. pii: 00006250-990000000-00400.
    >> Share

  66. GARIEPY AM, Lewis C, Zuckerman D, Tancredi DJ, et al
    Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
    Obstet Gynecol. 2022;139:423-432.
    >> Share

  67. DANVERS AA, Evans TA
    Risk of Sterilization Regret and Age: An Analysis of the National Survey of Family Growth, 2015-2019.
    Obstet Gynecol. 2022;139:433-439.
    >> Share

    February 2022
  68. STEENLAND MW, Rodriguez MI, Cohen JL
    Changes in the Supply Duration of Combined Oral Contraception During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2022 Feb 3. pii: 00006250-990000000-00386.
    >> Share


  69. Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.
    Obstet Gynecol. 2022;139:350-353.
    >> Share

    November 2021
  70. MAGNUSSON BM, Christensen SR, Tanner AB, Eyring JB, et al
    Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Obstet Gynecol. 2021 Nov 4. pii: 00006250-990000000-00334.
    >> Share

    October 2021
  71. BRANT AR, Kollikonda S, Yao M, Mei L, et al
    Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Obstet Gynecol. 2021 Oct 7. pii: 00006250-990000000-00308.
    >> Share

  72. BURLANDO AM, Flynn AN, Gutman S, McAllister A, et al
    The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2021;138:574-577.
    >> Share

  73. BOUMA-JOHNSTON H, Arora KS
    Website Review of Variation in Individual State Medicaid Sterilization Policies.
    Obstet Gynecol. 2021;138:578-579.
    >> Share

  74. BOHN JA, Bullard KA, Rodriguez MI, Ecker AM, et al
    Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2021;138:557-564.
    >> Share

    August 2021
  75. WU JP, Zhang J, McKee M, Akobirshoev I, et al
    Contraceptive Provision and Quality Care Measures for Insured Individuals in Massachusetts Who Are Deaf or Hard of Hearing.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00251.
    >> Share

  76. SCHAUB AM, Pisarska MD, Wright KN
    Intrauterine Adhesions After Chlamydia Infection With a Levonorgestrel-Releasing Intrauterine Device in Place.
    Obstet Gynecol. 2021 Aug 5. pii: 00006250-990000000-00258.
    >> Share


  77. Access to Postabortion Contraception: ACOG Committee Opinion, Number 833.
    Obstet Gynecol. 2021;138:e91-e95.
    >> Share


  78. Access to Postabortion Contraception: ACOG Committee Opinion Summary, Number 833.
    Obstet Gynecol. 2021;138:324-325.
    >> Share

    July 2021
  79. BAKENRA A, Gero A, Sanders J, Simmons R, et al
    Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    Obstet Gynecol. 2021;138:79-84.
    >> Share

  80. ARORA KS, Ponsaran R, Morello L, Katabi L, et al
    Obstetrician-Gynecologists' Practices in Postpartum Sterilization Without a Valid Medicaid Consent Form.
    Obstet Gynecol. 2021;138:66-72.
    >> Share

    June 2021

  81. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol. 2021;137:e100-e115.
    >> Share


  82. Access to Postpartum Sterilization: ACOG Committee Opinion, Number 827.
    Obstet Gynecol. 2021;137:e169-e176.
    >> Share

    May 2021
  83. HAMDAOUI N, Cardinale C, Fabre C, Baumstarck K, et al
    Pain Associated With Cervical Priming for First-Trimester Surgical Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 May 6. pii: 00006250-990000000-00191.
    >> Share

    April 2021
  84. COLEMAN-MINAHAN K, Ela EJ, White K, Grossman D, et al
    Contraindications to Hormonal Contraception Among Postpartum Women in Texas.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00175.
    >> Share

  85. ALLANSON ER, Copson S, Spilsbury K, Criddle S, et al
    Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial.
    Obstet Gynecol. 2021 Apr 8. pii: 00006250-990000000-00158.
    >> Share

  86. COHEN M, Edelman A, Bellussi F, Berghella V, et al
    Cochrane Review Summaries-April 2021.
    Obstet Gynecol. 2021;137:747-749.
    >> Share

    March 2021
  87. MEURICE ME, Lovio M, Chang JJ, Perry R, et al
    Contraception Choice Among Those Seeking Abortion for Fetal Indication or Management of Pregnancy Loss.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00125.
    >> Share

  88. BORAAS CM, Sanders JN, Schwarz EB, Thompson I, et al
    Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
    Obstet Gynecol. 2021 Mar 10. pii: 00006250-990000000-00136.
    >> Share


  89. Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
    Obstet Gynecol. 2021;137:e75-e88.
    >> Share

    February 2021
  90. AKTURK HK
    Locating Hormone-Releasing Contraceptive Implants Using Near-Infrared Light.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00117.
    >> Share

  91. ROLAND N, Drouin J, Desplas D, Cuenot F, et al
    Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France.
    Obstet Gynecol. 2021 Feb 4. pii: 00006250-990000000-00100.
    >> Share

    January 2021

  92. Options for Prevention and Management of Menstrual Bleeding in Adolescent Patients Undergoing Cancer Treatment: ACOG Committee Opinion, Number 817.
    Obstet Gynecol. 2021;137:e7-e15.
    >> Share

    December 2020
  93. GOLDMAN AR, Porsch L, Hintermeister A, Dragoman M, et al
    Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2020 Dec 3. doi: 10.1097/AOG.0000000000004208.
    >> Share

    November 2020

  94. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion, Number 813.
    Obstet Gynecol. 2020;136:e90-e99.
    >> Share


  95. Gynecologic Considerations for Adolescents and Young Women With Cardiac Conditions: ACOG Committee Opinion Summary, Number 813.
    Obstet Gynecol. 2020;136:1072-1073.
    >> Share

    October 2020
  96. FERRIES-ROWE E, Corey E, Archer JS
    Primary Dysmenorrhea: Diagnosis and Therapy.
    Obstet Gynecol. 2020 Oct 8. doi: 10.1097/AOG.0000000000004096.
    >> Share


  97. Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin Summary, Number 225.
    Obstet Gynecol. 2020;136:855-858.
    >> Share

    September 2020
  98. BERKLEY HH, Greene HL, Wittenberger MD
    Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2020 Sep 10. doi: 10.1097/AOG.0000000000004063.
    >> Share

    August 2020
  99. CREININ MD, Grossman DA
    Medication Abortion Up to 70 Days of Gestation.
    Obstet Gynecol. 2020 Aug 12. doi: 10.1097/AOG.0000000000004082.
    >> Share

  100. LEININGER WM, Gupta P
    One Hundred Years of Women's Suffrage: Health Care Advocacy, and Why We Vote.
    Obstet Gynecol. 2020;136:349-353.
    >> Share

    June 2020
  101. SPOTNITZ ME, Natarajan K, Ryan PB, Westhoff CL, et al
    In Reply.
    Obstet Gynecol. 2020;135:1487.
    >> Share

  102. SEL G, Yasar O, Aynali B, Dincer F, et al
    Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.
    Obstet Gynecol. 2020;135:1486-1487.
    >> Share

  103. SIMON JA, Al-Hendy A, Archer DF, Barnhart KT, et al
    Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Obstet Gynecol. 2020;135:1313-1326.
    >> Share

  104. FLOYD JL, Beasley AD, Swaim LS, Turrentine MA, et al
    Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Obstet Gynecol. 2020;135:1275-1280.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016